Global Antiretroviral Therapy Market Insights, Forecast to 2025
- QYR2789049
- 111 Pages
- October 2018
- Medical Devices
This report studies the global market size of Antiretroviral Therapy in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antiretroviral Therapy in these regions.
This research report categorizes the global Antiretroviral Therapy market by top players/brands, region, type and end user. This report also studies the global Antiretroviral Therapy market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Gilead
F. Hoffmann-La Roche
ViiV Healthcare
Boehringer Ingelheim
Janssen Pharmaceuticals
Mylan
Abbvie
Bionor Pharma
Vertex Pharmaceuticals
Market size by Product
NNRTIs
NRTI
Multiclass Combination Products
Integrase Inhibitors
Market size by End User
Hospital
Clinic
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Antiretroviral Therapy market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.
To understand the structure of Antiretroviral Therapy market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antiretroviral Therapy companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antiretroviral Therapy submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antiretroviral Therapy are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antiretroviral Therapy market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Antiretroviral Therapy Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antiretroviral Therapy Market Size Growth Rate by Product
1.4.2 NNRTIs
1.4.3 NRTI
1.4.4 Multiclass Combination Products
1.4.5 Integrase Inhibitors
1.5 Market by End User
1.5.1 Global Antiretroviral Therapy Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antiretroviral Therapy Market Size
2.1.1 Global Antiretroviral Therapy Revenue 2013-2025
2.1.2 Global Antiretroviral Therapy Sales 2013-2025
2.2 Antiretroviral Therapy Growth Rate by Regions
2.2.1 Global Antiretroviral Therapy Sales by Regions
2.2.2 Global Antiretroviral Therapy Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Antiretroviral Therapy Sales by Manufacturers
3.1.1 Antiretroviral Therapy Sales by Manufacturers
3.1.2 Antiretroviral Therapy Sales Market Share by Manufacturers
3.1.3 Global Antiretroviral Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Antiretroviral Therapy Revenue by Manufacturers
3.2.1 Antiretroviral Therapy Revenue by Manufacturers (2013-2018)
3.2.2 Antiretroviral Therapy Revenue Share by Manufacturers (2013-2018)
3.3 Antiretroviral Therapy Price by Manufacturers
3.4 Antiretroviral Therapy Manufacturing Base Distribution, Product Types
3.4.1 Antiretroviral Therapy Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antiretroviral Therapy Product Type
3.4.3 Date of International Manufacturers Enter into Antiretroviral Therapy Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Antiretroviral Therapy Sales by Product
4.2 Global Antiretroviral Therapy Revenue by Product
4.3 Antiretroviral Therapy Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Antiretroviral Therapy Breakdown Data by End User
6 North America
6.1 North America Antiretroviral Therapy by Countries
6.1.1 North America Antiretroviral Therapy Sales by Countries
6.1.2 North America Antiretroviral Therapy Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Antiretroviral Therapy by Product
6.3 North America Antiretroviral Therapy by End User
7 Europe
7.1 Europe Antiretroviral Therapy by Countries
7.1.1 Europe Antiretroviral Therapy Sales by Countries
7.1.2 Europe Antiretroviral Therapy Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antiretroviral Therapy by Product
7.3 Europe Antiretroviral Therapy by End User
8 Asia Pacific
8.1 Asia Pacific Antiretroviral Therapy by Countries
8.1.1 Asia Pacific Antiretroviral Therapy Sales by Countries
8.1.2 Asia Pacific Antiretroviral Therapy Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Antiretroviral Therapy by Product
8.3 Asia Pacific Antiretroviral Therapy by End User
9 Central & South America
9.1 Central & South America Antiretroviral Therapy by Countries
9.1.1 Central & South America Antiretroviral Therapy Sales by Countries
9.1.2 Central & South America Antiretroviral Therapy Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Antiretroviral Therapy by Product
9.3 Central & South America Antiretroviral Therapy by End User
10 Middle East and Africa
10.1 Middle East and Africa Antiretroviral Therapy by Countries
10.1.1 Middle East and Africa Antiretroviral Therapy Sales by Countries
10.1.2 Middle East and Africa Antiretroviral Therapy Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Antiretroviral Therapy by Product
10.3 Middle East and Africa Antiretroviral Therapy by End User
11 Company Profiles
11.1 Gilead
11.1.1 Gilead Company Details
11.1.2 Company Business Overview
11.1.3 Gilead Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)
11.1.4 Gilead Antiretroviral Therapy Products Offered
11.1.5 Gilead Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Details
11.2.2 Company Business Overview
11.2.3 F. Hoffmann-La Roche Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)
11.2.4 F. Hoffmann-La Roche Antiretroviral Therapy Products Offered
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 ViiV Healthcare
11.3.1 ViiV Healthcare Company Details
11.3.2 Company Business Overview
11.3.ViiV Healthcare Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)
11.3.4 ViiV Healthcare Antiretroviral Therapy Products Offered
11.3.5 ViiV Healthcare Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Details
11.4.2 Company Business Overview
11.4.3 Boehringer Ingelheim Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)
11.4.4 Boehringer Ingelheim Antiretroviral Therapy Products Offered
11.4.5 Boehringer Ingelheim Recent Development
11.5 Janssen Pharmaceuticals
11.5.1 Janssen Pharmaceuticals Company Details
11.5.2 Company Business Overview
11.5.3 Janssen Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)
11.5.4 Janssen Pharmaceuticals Antiretroviral Therapy Products Offered
11.5.5 Janssen Pharmaceuticals Recent Development
11.6 Mylan
11.6.1 Mylan Company Details
11.6.2 Company Business Overview
11.6.3 Mylan Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)
11.6.4 Mylan Antiretroviral Therapy Products Offered
11.6.5 Mylan Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Company Business Overview
11.7.3 Abbvie Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)
11.7.4 Abbvie Antiretroviral Therapy Products Offered
11.7.5 Abbvie Recent Development
11.8 Bionor Pharma
11.8.1 Bionor Pharma Company Details
11.8.2 Company Business Overview
11.8.3 Bionor Pharma Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)
11.8.4 Bionor Pharma Antiretroviral Therapy Products Offered
11.8.5 Bionor Pharma Recent Development
11.9 Vertex Pharmaceuticals
11.9.1 Vertex Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Vertex Pharmaceuticals Antiretroviral Therapy Sales, Revenue and Gross Margin (2013-2018)
11.9.4 Vertex Pharmaceuticals Antiretroviral Therapy Products Offered
11.9.5 Vertex Pharmaceuticals Recent Development
12 Future Forecast
12.1 Antiretroviral Therapy Market Forecast by Regions
12.1.1 Global Antiretroviral Therapy Sales Forecast by Regions 2018-2025
12.1.2 Global Antiretroviral Therapy Revenue Forecast by Regions 2018-2025
12.2 Antiretroviral Therapy Market Forecast by Product
12.2.1 Global Antiretroviral Therapy Sales Forecast by Product 2018-2025
12.2.2 Global Antiretroviral Therapy Revenue Forecast by Product 2018-2025
12.3 Antiretroviral Therapy Market Forecast by End User
12.4 North America Antiretroviral Therapy Forecast
12.5 Europe Antiretroviral Therapy Forecast
12.6 Asia Pacific Antiretroviral Therapy Forecast
12.7 Central & South America Antiretroviral Therapy Forecast
12.8 Middle East and Africa Antiretroviral Therapy Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antiretroviral Therapy Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Antiretroviral Therapy Product Picture
Table Antiretroviral Therapy Market Segments
Table Key Manufacturers Antiretroviral Therapy Covered
Table Global Antiretroviral Therapy Market Size Growth Rate by Product 2018-2025 (K Units) & (Million US$)
Figure Global Antiretroviral Therapy Sales Market Share by Product 2013-2025
Figure NNRTIs Product Picture
Table Major Manufacturers of NNRTIs
Figure NRTI Product Picture
Table Major Manufacturers of NRTI
Figure Multiclass Combination Products Product Picture
Table Major Manufacturers of Multiclass Combination Products
Figure Integrase Inhibitors Product Picture
Table Major Manufacturers of Integrase Inhibitors
Table Global Antiretroviral Therapy Market Size Growth Rate by End User 2018-2025 (K Units)
Figure Hospital
Figure Clinic
Figure Other
Figure Antiretroviral Therapy Report Years Considered
Figure Global Antiretroviral Therapy Market Size 2013-2025 (Million US$)
Figure Global Antiretroviral Therapy Sales 2013-2025 (K Units)
Table Global Antiretroviral Therapy Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global Antiretroviral Therapy Sales by Regions 2013-2018 (K Units)
Table Global Antiretroviral Therapy Sales Market Share by Regions 2013-2018
Figure Global Antiretroviral Therapy Sales Market Share by Regions 2013-2018
Figure 2017 Global Antiretroviral Therapy Sales Market Share by Regions
Table Global Antiretroviral Therapy Revenue by Regions 2013-2018 (Million US$)
Table Global Antiretroviral Therapy Revenue Market Share by Regions 2013-2018
Figure Global Antiretroviral Therapy Revenue Market Share by Regions 2013-2018
Figure 2017 Global Antiretroviral Therapy Revenue Market Share by Regions
Table Global Antiretroviral Therapy Sales by Manufacturers (2013-2018) (K Units)
Table Global Antiretroviral Therapy Sales Share by Manufacturers (2013-2018)
Figure Global Antiretroviral Therapy Sales Share by Manufacturers in 2017
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Antiretroviral Therapy Revenue by Manufacturers (2013-2018) (Million USD)
Table Antiretroviral Therapy Revenue Share by Manufacturers (2013-2018)
Figure Antiretroviral Therapy Value Share by Manufacturers in 2017
Table Key Manufacturers Antiretroviral Therapy Price (2013-2018) (USD/Unit)
Table Antiretroviral Therapy Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Antiretroviral Therapy Product Type
Table Date of International Manufacturers Enter into Antiretroviral Therapy Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Antiretroviral Therapy Sales by Product (2013-2018) (K Units)
Table Global Antiretroviral Therapy Sales Share by Product (2013-2018)
Figure Global Antiretroviral Therapy Sales Market Share by Product (2013-2018)
Figure Global Antiretroviral Therapy Sales Market Share by Product in 2017
Table Global Antiretroviral Therapy Revenue by Product (2013-2018) (Million US$)
Table Global Antiretroviral Therapy Revenue Share by Product (2013-2018)
Figure Global Antiretroviral Therapy Revenue Market Share by Product (2013-2018)
Figure Global Antiretroviral Therapy Revenue Market Share by Product in 2017
Table Antiretroviral Therapy Price by Product 2013-2018 (USD/Unit)
Table Global Antiretroviral Therapy Sales by End User (2013-2018) (K Units)
Table Global Antiretroviral Therapy Sales Share by End User (2013-2018)
Figure Global Sales Antiretroviral Therapy Market Share by End User (2013-2018)
Figure Global Sales Antiretroviral Therapy Market Share by End User in 2017
Figure North America Antiretroviral Therapy Sales Growth Rate 2013-2018 (K Units)
Figure North America Antiretroviral Therapy Revenue Growth Rate 2013-2018 (Million US$)
Table North America Antiretroviral Therapy Sales by Countries (2013-2018) (K Units)
Table North America Antiretroviral Therapy Sales Market Share by Countries (2013-2018)
Figure 2017 North America Antiretroviral Therapy Sales Market Share by Countries
Table North America Antiretroviral Therapy Revenue by Countries (2013-2018) (Million US$)
Table North America Antiretroviral Therapy Revenue Market Share by Countries (2013-2018)
Figure 2017 North America Antiretroviral Therapy Revenue Market Share by Countries
Figure United States Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure United States Antiretroviral Therapy Revenue Growth Rate (2013-2018) (K Units)
Figure Canada Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Canada Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Mexico Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Mexico Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Table North America Antiretroviral Therapy Sales by Product (2013-2018) (K Units)
Table North America Antiretroviral Therapy Sales Market Share by Product (2013-2018)
Figure 2017 North America Antiretroviral Therapy Market Share by Product
Table North America Antiretroviral Therapy Sales by End User (2013-2018) (K Units)
Table North America Antiretroviral Therapy Sales Market Share by End User (2013-2018)
Figure 2017 North America Antiretroviral Therapy Market Share by End User
Figure Europe Antiretroviral Therapy Sales Growth Rate 2013-2018 (K Units)
Figure Europe Antiretroviral Therapy Revenue Growth Rate 2013-2018 (Million US$)
Table Europe Antiretroviral Therapy Sales by Countries (2013-2018) (K Units)
Table Europe Antiretroviral Therapy Sales Market Share by Countries (2013-2018)
Figure 2017 Europe Antiretroviral Therapy Sales Market Share by Countries
Table Europe Antiretroviral Therapy Revenue by Countries (2013-2018) (Million US$)
Table Europe Antiretroviral Therapy Revenue Market Share by Countries (2013-2018)
Figure 2017 Europe Antiretroviral Therapy Revenue Market Share by Countries
Figure Germany Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Germany Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure France Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure France Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure UK Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure UK Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Italy Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Italy Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Russia Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Russia Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Table Europe Antiretroviral Therapy Sales by Product (2013-2018) (K Units)
Table Europe Antiretroviral Therapy Sales Market Share by Product (2013-2018)
Figure 2017 Europe Antiretroviral Therapy Market Share by Product
Table Europe Antiretroviral Therapy Sales by End User (2013-2018) (K Units)
Table Europe Antiretroviral Therapy Sales Market Share by End User (2013-2018)
Figure 2017 Europe Antiretroviral Therapy Market Share by End User
Figure Asia Pacific Antiretroviral Therapy Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific Antiretroviral Therapy Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific Antiretroviral Therapy Sales by Countries (2013-2018) (K Units)
Table Asia Pacific Antiretroviral Therapy Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Antiretroviral Therapy Sales Market Share by Countries
Table Asia Pacific Antiretroviral Therapy Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific Antiretroviral Therapy Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific Antiretroviral Therapy Revenue Market Share by Countries
Figure China Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure China Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Japan Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Korea Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure India Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure India Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Australia Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Philippines Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Thailand Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Singapore Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Singapore Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Table Asia Pacific Antiretroviral Therapy Sales by Product (2013-2018) (K Units)
Table Asia Pacific Antiretroviral Therapy Sales Market Share by Product (2013-2018)
Figure 2017 Asia Pacific Antiretroviral Therapy Market Share by Product
Table Asia Pacific Antiretroviral Therapy Sales by End User (2013-2018) (K Units)
Table Asia Pacific Antiretroviral Therapy Sales Market Share by End User (2013-2018)
Figure 2017 Asia Pacific Antiretroviral Therapy Market Share by End User
Figure Central & South America Antiretroviral Therapy Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America Antiretroviral Therapy Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America Antiretroviral Therapy Sales by Countries (2013-2018) (K Units)
Table Central & South America Antiretroviral Therapy Sales Market Share by Countries (2013-2018)
Figure 2017 Central & South America Antiretroviral Therapy Sales Market Share by Countries
Table Central & South America Antiretroviral Therapy Revenue by Countries (2013-2018) (Million US$)
Table Central & South America Antiretroviral Therapy Revenue Market Share by Countries (2013-2018)
Figure 2017 Central & South America Antiretroviral Therapy Revenue Market Share by Countries
Figure Brazil Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Brazil Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Argentina Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Argentina Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Table Central & South America Antiretroviral Therapy Sales by Product (2013-2018) (K Units)
Table Central & South America Antiretroviral Therapy Sales Market Share by Product (2013-2018)
Figure 2017 Central & South America Antiretroviral Therapy Market Share by Product
Table Central & South America Antiretroviral Therapy Sales by End User (2013-2018) (K Units)
Table Central & South America Antiretroviral Therapy Sales Market Share by End User (2013-2018)
Figure 2017 Central & South America Antiretroviral Therapy Market Share by End User
Figure Middle East and Africa Antiretroviral Therapy Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa Antiretroviral Therapy Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa Antiretroviral Therapy Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa Antiretroviral Therapy Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Antiretroviral Therapy Sales Market Share by Countries
Table Middle East and Africa Antiretroviral Therapy Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa Antiretroviral Therapy Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa Antiretroviral Therapy Revenue Market Share by Countries
Figure GCC Countries Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Turkey Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Turkey Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure Egypt Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure Egypt Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Figure South Africa Antiretroviral Therapy Sales Growth Rate (2013-2018) (K Units)
Figure South Africa Antiretroviral Therapy Revenue Growth Rate (2013-2018) (Million US$)
Table Middle East and Africa Antiretroviral Therapy Sales by Product (2013-2018) (K Units)
Table Middle East and Africa Antiretroviral Therapy Sales Market Share by Product (2013-2018)
Figure 2017 Middle East and Africa Antiretroviral Therapy Market Share by Product
Table Middle East and Africa Antiretroviral Therapy Sales by End User (2013-2018) (K Units)
Table Middle East and Africa Antiretroviral Therapy Sales Market Share by End User (2013-2018)
Figure 2017 Middle East and Africa Antiretroviral Therapy Market Share by End User
Table Gilead Company Details
Table Gilead Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Gilead Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table F. Hoffmann-La Roche Recent Development
Table ViiV Healthcare Company Details
Table ViiV Healthcare Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table ViiV Healthcare Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Boehringer Ingelheim Recent Development
Table Janssen Pharmaceuticals Company Details
Table Janssen Pharmaceuticals Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Janssen Pharmaceuticals Recent Development
Table Mylan Company Details
Table Mylan Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Mylan Recent Development
Table Abbvie Company Details
Table Abbvie Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Abbvie Recent Development
Table Bionor Pharma Company Details
Table Bionor Pharma Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bionor Pharma Recent Development
Table Vertex Pharmaceuticals Company Details
Table Vertex Pharmaceuticals Antiretroviral Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Vertex Pharmaceuticals Recent Development
Table Global Antiretroviral Therapy Sales Forecast by Regions 2018-2025 (K Units)
Table Global Antiretroviral Therapy Sales Market Share Forecast by Regions 2018-2025
Table Global Antiretroviral Therapy Revenue Forecast by Regions 2018-2025 (Million US$)
Table Global Antiretroviral Therapy Revenue Market Share Forecast by Regions 2018-2025
Table Global Antiretroviral Therapy Sales Forecast by Product 2018-2025 (K Units)
Table Global Antiretroviral Therapy Sales Market Share Forecast by Product 2018-2025
Table Global Antiretroviral Therapy Revenue Forecast by Product 2018-2025 (Million US$)
Table Global Antiretroviral Therapy Revenue Market Share Forecast by Product 2018-2025
Table Global Antiretroviral Therapy Sales Forecast by End User 2018-2025 (K Units)
Table Global Antiretroviral Therapy Sales Market Share Forecast by End User 2018-2025
Figure North America Antiretroviral Therapy Sales Growth Rate Forecast (2018-2025) (K Units)
Figure North America Antiretroviral Therapy Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Europe Antiretroviral Therapy Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Europe Antiretroviral Therapy Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Asia Pacific Antiretroviral Therapy Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Asia Pacific Antiretroviral Therapy Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Central & South America Antiretroviral Therapy Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Central & South America Antiretroviral Therapy Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure Middle East and Africa Antiretroviral Therapy Sales Growth Rate Forecast (2018-2025) (K Units)
Figure Middle East and Africa Antiretroviral Therapy Revenue Growth Rate Forecast (2018-2025) (Million US$)
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Forecast of Global Middle-Class Population, 2015 to 2030
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016
Table Antiretroviral Therapy Value Chain
Table Antiretroviral Therapy Customers List
Table Antiretroviral Therapy Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
